Procymate

Summary

Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.

Procymate
Clinical data
Routes of
administration
By mouth
ATC code
  • none
Identifiers
  • carbamic acid 1-cyclohexylpropyl ester
CAS Number
  • 13931-64-1 checkY
PubChem CID
  • 3050432
ChemSpider
  • 2312494 ☒N
UNII
  • 308EUN932K
ChEMBL
  • ChEMBL2104652 ☒N
Chemical and physical data
FormulaC10H19NO2
Molar mass185.267 g·mol−1
3D model (JSmol)
  • Interactive image
  • CCC(C1CCCCC1)OC(=O)N
  • InChI=1S/C10H19NO2/c1-2-9(13-10(11)12)8-6-4-3-5-7-8/h8-9H,2-7H2,1H3,(H2,11,12) ☒N
  • Key:IGISNRIWPJVXDB-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References edit

  1. ^ "Procymate". Bank of Automated Data on Drugs. VIDAL Drug Database. Archived from the original on 12 January 2008.